Want to see IN:HCG full AI Analyst Report?
Top Page
HealthCare Global Enterprises Ltd.
(HCG)
Select Model
Select Model
Rating:63Neutral
Price Target:
₹623.00
▼(-6.49% Downside)
Action:Reiterated
Date:08/21/26
The score is primarily held back by weak profitability and a leveraged balance sheet despite strong operating cash flow trends. Technical indicators are constructive and support near-term momentum, but the very high P/E meaningfully reduces the overall attractiveness.
Positive Factors
Revenue Scale
The substantial five-year increase in revenue demonstrates that HCG has expanded its oncology-care platform and patient-service base. Greater operating scale can support broader clinical capabilities, improve fixed-cost absorption, and provide a stronger foundation for sustained growth over the next several quarters.
Negative Factors
High Leverage
HCG remains dependent on a debt-heavy capital structure, with total debt exceeding equity and debt rising materially since FY2023. This increases sensitivity to interest costs and operating volatility, potentially restricting capital allocation and weakening resilience if profitability remains subdued.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Scale
The substantial five-year increase in revenue demonstrates that HCG has expanded its oncology-care platform and patient-service base. Greater operating scale can support broader clinical capabilities, improve fixed-cost absorption, and provide a stronger foundation for sustained growth over the next several quarters.
Read all positive factors
HealthCare Global Enterprises Ltd. (HCG) vs. iShares MSCI India ETF (INDA)
Market Cap
₹87.31B
Dividend YieldN/A
Average Volume (3M)19.82K
Price to Earnings (P/E)375.4
Beta (1Y)0.57
Revenue Growth13.65%
EPS Growth-40.97%
CountryIN
Employees6,761
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)1.56
Shares Outstanding149,302,200
10 Day Avg. Volume5,589
30 Day Avg. Volume19,818
Financial Highlights & Ratios
PEG Ratio-7.78
Price to Book (P/B)5.59
Price to Sales (P/S)2.93
P/FCF Ratio135.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)8.92
Revenue Forecast (FY)₹29.06B
HealthCare Global Enterprises Ltd. Business Overview & Revenue Model
Company Description
HealthCare Global Enterprises Limited, founded in 1989 and headquartered in Bengaluru, India, delivers comprehensive healthcare services with a primary focus on oncology. The company offers a full spectrum of cancer care, from diagnosis to various...
HealthCare Global Enterprises Ltd. Financial Statement Overview
Summary
Income Statement
66
Positive
Balance Sheet
54
Neutral
Cash Flow
71
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.20B | 25.38B | 22.23B | 19.12B | 16.94B | 13.98B |
| Gross Profit | 10.25B | 12.97B | 11.91B | 10.48B | 9.20B | 7.52B |
| EBITDA | 4.68B | 4.48B | 3.89B | 3.30B | 2.99B | 2.38B |
| Net Income | 227.80M | 137.60M | 444.10M | 481.55M | 293.49M | 537.33M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 39.23B | 35.43B | 27.07B | 23.16B | 22.20B |
| Cash, Cash Equivalents and Short-Term Investments | 5.41B | 5.52B | 3.53B | 3.03B | 1.97B | 2.04B |
| Total Debt | 0.00 | 17.35B | 18.37B | 12.74B | 9.01B | 9.15B |
| Total Liabilities | -14.10B | 25.12B | 25.53B | 18.42B | 14.47B | 13.36B |
| Stockholders Equity | 14.10B | 13.32B | 9.22B | 8.26B | 8.61B | 8.70B |
Cash Flow | ||||||
| Free Cash Flow | 339.30M | 550.00M | 1.08B | 988.99M | 1.18B | 1.49B |
| Operating Cash Flow | 1.92B | 3.47B | 3.17B | 2.85B | 2.52B | 2.20B |
| Investing Cash Flow | -580.00M | -1.77B | -4.88B | -2.26B | -1.33B | 1.25B |
| Financing Cash Flow | -806.50M | 2.41B | -424.40M | -640.16M | -1.40B | -1.55B |
HealthCare Global Enterprises Ltd. Technical Analysis
Negative
666.25
Price Trends
662.01
Negative
660.08
Negative
625.59
Negative
Market Momentum
-25.37
Negative
39.90
Neutral
79.89
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:HCG, the sentiment is Negative. The current price of 666.25 is above the 20-day moving average (MA) of 598.92, above the 50-day MA of 662.01, and above the 200-day MA of 625.59, indicating a bearish trend. The MACD of -25.37 indicates Negative momentum. The RSI at 39.90 is Neutral, neither overbought nor oversold. The STOCH value of 79.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:HCG.
HealthCare Global Enterprises Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ₹341.22B | 61.37 | ― | 0.08% | 21.27% | 4.09% | |
64 Neutral | ₹595.70B | 110.40 | ― | 0.59% | 15.70% | -2.76% | |
63 Neutral | ₹87.31B | 375.35 | ― | ― | 13.65% | -40.97% | |
60 Neutral | ₹581.17B | 55.34 | ― | 0.13% | 17.50% | 20.65% | |
59 Neutral | ₹1.21T | 58.13 | ― | 0.24% | 17.20% | 32.79% | |
55 Neutral | ₹837.05B | 57.45 | ― | 0.23% | 15.96% | 26.87% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
IN:HCG
HealthCare Global Enterprises Ltd.
584.80
-162.98
-21.79%
IN:APOLLOHOSP
Apollo Hospitals Enterprise Limited
8,400.00
594.57
7.62%
IN:ASTERDM
Aster DM Healthcare Ltd.
683.40
4.80
0.71%
IN:FORTIS
Fortis Healthcare Ltd.
769.80
-259.46
-25.21%
IN:MAXHEALTH
Max Healthcare Institute Ltd
860.00
-284.47
-24.86%
IN:MEDANTA
Global Health Limited
1,269.05
-6.25
-0.49%
HealthCare Global Enterprises Ltd. Corporate Events
HealthCare Global Enterprises Confirms SEBI Compliance on Share Dematerialization
Oct 15, 2026
HealthCare Global Enterprises Ltd. has reported compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The company confirmed that all dematerialization and remateria...
HCG Secures Shareholder Nod for All Resolutions at 28th AGM
Sep 18, 2026
HealthCare Global Enterprises Ltd. reported that its 28th Annual General Meeting was held on September 18, 2026, via video conferencing and other audio-visual means in compliance with MCA and SEBI guidelines. The company said all resolutions propo...
HealthCare Global Publishes Q1 FY27 Unaudited Results in Line with SEBI Norms
Aug 8, 2026
HealthCare Global Enterprises Ltd. has published its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, as approved by its board on August 6, 2026. The results have been advertised in leading English and K...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.